Better Coronavirus Stock: Sorrento Therapeutics vs. Vaxart

Better Coronavirus Stock: Sorrento Therapeutics vs. Vaxart

Two that particularly stand out are Sorrento Therapeutics (NASDAQ: SRNE) and Vaxart (NASDAQ: VXRT). Vaxart stock has skyrocketed more than 43 times higher so far in 2020. The drug hasn't been in Sorrento's pipeline for very long; the company announced that it was licensing the rights to abivertinib outside of China from ACEA Therapeutics in May.